Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer (Q33712476)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer |
scientific article |
Statements
1 reference
Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer (English)
1 reference
Eric P Winer
1 reference
William Sikov
1 reference
George Somlo
1 reference
Ian E Krop
1 reference
Vinay Varadan
1 reference
Hannah Gilmore
1 reference
Kristy L S Miskimen
1 reference
David Tuck
1 reference
Shikha Parsai
1 reference
Amad Awadallah
1 reference
Veerle Bossuyt
1 reference
Maysa M Abu-Khalaf
1 reference
Mary Anne Fenton
1 reference
Lyndsay N Harris
1 reference
3 February 2016
1 reference
1 reference
1 reference
Identifiers
1 reference